As of 2025-07-11, the Intrinsic Value of XSpray Pharma AB (publ) (XSPRAY.ST) is -35.01 SEK. This XSPRAY.ST valuation is based on the model Peter Lynch Fair Value. With the current market price of 48.70 SEK, the upside of XSpray Pharma AB (publ) is -171.89%.
Based on its market price of 48.70 SEK and our intrinsic valuation, XSpray Pharma AB (publ) (XSPRAY.ST) is overvalued by 171.89%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -35.01 - -35.01 | -35.01 | -171.89% |
| P/E | (123.24) - (173.24) | (154.41) | -417.1% |
| DDM - Stable | (95.27) - 20,151.53 | 10,028.14 | 20491.7% |
| DDM - Multi | (99.40) - 16,868.71 | (203.09) | -517.0% |
| Market Cap (mil) | 1,808.72 |
| Beta | 1.34 |
| Outstanding shares (mil) | 37.14 |
| Enterprise Value (mil) | 1,809.95 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.56% |
| Cost of Debt | 5.00% |
| WACC | 6.38% |